The article details two options strategies for Gilead Sciences (GILD) at $113.11, offering yield enhancement and specific entry/exit points. Selling a $110.00 strike put for an $8.05 premium provides a potential entry at an effective $101.95 cost basis, with a 60% chance of expiring worthless for an 11.18% annualized premium yield. Alternatively, a covered call strategy, selling a $115.00 strike call for a $9.45 premium against held shares, projects a 10.03% return if assigned by May 2026, or a 12.76% annualized premium yield if the option expires worthless with a 47% probability. Both strategies leverage GILD's approximately 29% implied volatility, closely aligning with its 28% trailing 12-month actual volatility.
The analysis highlights two specific, yield-focused options strategies for Gilead Sciences (GILD), currently trading at $113.11 per share. The first strategy involves selling a cash-secured put at the $110.00 strike price for a premium of $8.05. This establishes a potential acquisition cost basis of $101.95, a discount to the current price, should the shares be assigned. Alternatively, if the put expires worthless, which has a stated probability of 60%, the seller realizes an 11.18% annualized return on the cash commitment. The second strategy is a covered call for existing shareholders, involving the sale of a $115.00 strike call for a $9.45 premium. This caps the total return at 10.03% if the stock is called away by the May 2026 expiration but provides an annualized premium yield of 12.76% if the option expires worthless (a 47% probability). A key observation is that the options' implied volatility of approximately 29% is closely aligned with GILD's trailing twelve-month actual volatility of 28%, suggesting the premiums are fairly priced relative to the stock's recent price behavior.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
